22nd Century Group Inc. [AMEX: XXII] plunged by -$0.54 during the normal trading session on Wednesday and reaching a high of $3.22 during the day while it closed the day at $2.47. The company report on March 3, 2021 that 22nd Century Group Secures Exclusive Agreement with CannaMetrix to Accelerate Commercialization of New, Disruptive Hemp/Cannabis Plant Lines and Intellectual Property.
High-throughput technology will dramatically advance and reduce timeframe for bringing valuable, commercial hemp/cannabis plant lines and intellectual property to market in two years.
22nd Century Group, Inc. (NYSE American: XXII), a leading plant-based, biotechnology company that is focused on tobacco harm reduction, very low nicotine content tobacco, and hemp/cannabis research, announced that it has secured an exclusive agreement with CannaMetrix, LLC for the use of their proprietary, human cell-based testing CannaMetrix EC50Array™ technology that will enable 22nd Century to accelerate the commercialization of new, disruptive hemp/cannabis plant lines and intellectual property.
22nd Century Group Inc. stock has also loss -38.25% of its value over the past 7 days. However, XXII stock has inclined by 55.35% in the 3 months of the year. Over the past six months meanwhile, it has gained 318.72% and gained 12.27% year-on date.
The market cap for XXII stock reached $349.11 million, with 138.86 million shares outstanding and 136.27 million shares in the current float. Compared to the average trading volume of 3.82M shares, XXII reached a trading volume of 7934245 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about 22nd Century Group Inc. [XXII]:
Chardan Capital Markets have made an estimate for 22nd Century Group Inc. shares, keeping their opinion on the stock as Buy, with their previous recommendation back on October 16, 2017. While these analysts kept the previous recommendation, Chardan Capital Markets dropped their target price from $4.50 to $3.50. The new note on the price target was released on August 11, 2016, representing the official price target for 22nd Century Group Inc. stock.
The Average True Range (ATR) for 22nd Century Group Inc. is set at 0.41, with the Price to Sales ratio for XXII stock in the period of the last 12 months amounting to 12.42. The Price to Book ratio for the last quarter was 6.86, with the Price to Cash per share for the same quarter was set at 0.19.
XXII stock trade performance evaluation
22nd Century Group Inc. [XXII] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -38.25. With this latest performance, XXII shares dropped by -0.40% in over the last four-week period, additionally plugging by 318.72% over the last 6 months – not to mention a rise of 216.42% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for XXII stock in for the last two-week period is set at 34.63, with the RSI for the last a single of trading hit 25.63, and the three-weeks RSI is set at 40.76 for 22nd Century Group Inc. [XXII]. The present Moving Average for the last 50 days of trading for this stock 2.91, while it was recorded at 3.11 for the last single week of trading, and 1.40 for the last 200 days.
22nd Century Group Inc. [XXII]: An insightful look at the core fundamentals
Operating Margin for any stock indicates how profitable investing would be, and 22nd Century Group Inc. [XXII] shares currently have an operating margin of -86.81 and a Gross Margin at -5.46. 22nd Century Group Inc.’s Net Margin is presently recorded at -102.81.
Return on Total Capital for XXII is now -32.89, given the latest momentum, and Return on Invested Capital for the company is -39.39. Return on Equity for this stock declined to -39.84, with Return on Assets sitting at -36.32. When it comes to the capital structure of this company, 22nd Century Group Inc. [XXII] has a Total Debt to Total Equity ratio set at 2.38. Additionally, XXII Total Debt to Total Capital is recorded at 2.32, with Total Debt to Total Assets ending up at 2.14. Long-Term Debt to Equity for the company is recorded at 1.09, with the Long-Term Debt to Total Capital now at 1.06.
Reflecting on the efficiency of the workforce at the company, 22nd Century Group Inc. [XXII] managed to generate an average of -$396,396 per employee. Receivables Turnover for the company is 29.72 with a Total Asset Turnover recorded at a value of 0.35.22nd Century Group Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 4.70 and a Current Ratio set at 5.10.
22nd Century Group Inc. [XXII]: Insider Ownership positions
There are presently around $64 million, or 23.90% of XXII stock, in the hands of institutional investors. The top three institutional holders of XXII stocks are: ETF MANAGERS GROUP, LLC with ownership of 6,687,621, which is approximately -32.873% of the company’s market cap and around 0.80% of the total institutional ownership; VANGUARD GROUP INC, holding 5,841,574 shares of the stock with an approximate value of $14.43 million in XXII stocks shares; and MILLENNIUM MANAGEMENT LLC, currently with $6.65 million in XXII stock with ownership of nearly 426.021% of the company’s market capitalization.
Positions in 22nd Century Group Inc. stocks held by institutional investors increased at the end of March and at the time of the March reporting period, where 50 institutional holders increased their position in 22nd Century Group Inc. [AMEX:XXII] by around 5,257,918 shares. Additionally, 31 investors decreased positions by around 4,422,066 shares, while 25 investors held positions by with 16,191,997 shares. The mentioned changes placed institutional holdings at 25,871,981 shares, according to the latest SEC report filing. XXII stock had 26 new institutional investments in for a total of 1,342,420 shares, while 10 institutional investors sold positions of 277,443 shares during the same period.